Free Delivery on $50+* || Clinic Website
Providing Quality & Trust
Apoquel Tablet
Zoetis
Starting at $4.10
$4.10 Each
Detailed Description
APOQUEL® (oclacitinib tablet)
APOQUEL is the #1 prescribed medicine for allergic itch
Effective for flea allergy, food allergy, contact allergy, atopic dermatitis.
Apoquel is used to treat and control itching and inflammation in dogs resulting from a variety of causes, including flea allergy, food allergy, contact allergy and atopic dermatitis. Apoquel delivers onset of relief within 4 hours. It effectively controls itching within 24 hours. Apoquel requires a prescription from your veterinarian, and is sold per tablet.
|
|
APOQUEL® (oclacitinib tablet) has been prescribed to more than 8 million dogs in need of fast and effective allergic itch relief.
- Provides onset of relief within 4 hours
- Effectively controls itch within 24 hours
- Safe for short term and long term usage
- Can be used along with many other common medications, including parasiticides, antibiotics, and vaccines
- Uniquely targeted to stop the itch with minimal negative impact on immune function
- Controls pruritus associated with allergic dermatitis and controls atopic dermatitis
- Sold per tablet
Relieve allergic itch with APOQUEL during an 8-week food trial:The first step in providing allergic itch relief during diagnostic testing.APOQUEL lets you establish and maintain allergic itch relief while allowing you to achieve a diagnosis
|
APOQUEL is not a steroid.
First medicine specifically designed to target canine allergic itch and inflammation. Works differently from steroids and cyclosporine.
- Nonsteroidal APOQUEL targets specific cytokines that cause itch and inflammation, relieving symptoms of allergic skin disease with minimal impact on the immune system.
Short-term steroid use can cause side effects.
How to dose APOQUEL:
For more information see dosing guide. |
Safety:
The safety profile of APOQUEL is supported by pharmacovigilance data over 5 years
The overall adverse reactions incidence rate during a 5-year review is rare (more than 1 but less than 10 animals reacting per 10,000 treatments administered)
- The incidence rate of the most commonly reported individual adverse reactions (in decreasing order: vomiting, diarrhea, lethargy, anorexia and bloodwork changes) associated with the use of APOQUEL was very rare (less than 1 dog out of 10,000 treated)
- Results are consistent with pre-approval pivotal safety and efficacy studies. APOQUEL is performing as expected under field conditions
Safe to use in dogs 12 months of age and older.
Side effects were similar to placebo over short term
- Most common side effects in a short-term clinical trial included vomiting and diarrhea and were self-limiting
Can be used long term for maintenance therapy
Can be used concomitantly with many medications, including NSAIDs, anti-infectives, parasiticides, antifungals and allergen-specific immunotherapy
- The use of APOQUEL has not been evaluated in combination with other systemic immunosuppressants, such as corticosteroids and cyclosporine
Not for use in dogs with serious infections or for use in breeding, pregnant or lactating dogs
Indications:
Control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
Important Safety Information:
Do not use APOQUEL® (oclacitinib tablet) in dogs less than 12 months of age or those with serious infections. APOQUEL may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. APOQUEL has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporine. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. APOQUEL has been used safely with many common medications including parasiticides, antibiotics and vaccines.
For more information, please see the full Prescribing Information.
Powered by nopCommerce
This site is running in live payment mode. Real payments will be processed.